Synapse

← JHEP Reports

Papers in JHEP Reports

Page 5 · newest first

  1. Prognostic implications of tumour number in intrahepatic cholangiocarcinomaJHEP Reports · 2026
  2. CAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse modelsJHEP Reports · 2026
  3. Identifying sorafenib benefit among patients with hepatocellular carcinoma: A transcriptomic and genomic approachJHEP Reports · 2026
  4. Non-invasive tests to guide hepatocellular carcinoma surveillanceJHEP Reports · 2026
  5. Single-photon emission computed tomography functional liver imaging to facilitate reirradiation for liver malignancies: A phase I trialJHEP Reports · 2026
  6. HCC recurrence in liver transplants treated with hypothermic oxygenated machine perfusion: An international matched cohort studyJHEP Reports · 2026
  7. Spatial transcriptional profiling of CHB liver biopsies reveals an undetected population of zonally biased HBV-integrated cellsJHEP Reports · 2026
  8. Fibrosis activity vs. disease stage: Complementary and independent predictors of outcomes in alcohol-related liver diseaseJHEP Reports · 2026
  9. The Elucidating Pathways of Steatohepatitis (EPoS) staging system: A reproducible 7-tiered fibrosis scoring system in MASLDJHEP Reports · 2026
  10. Serpine1 as a potential therapeutic target in pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndromeJHEP Reports · 2026
  11. Plasma GPC3 reflects tumor GPC3 expression and predicts clinical outcomes in advanced HCC treated with atezolizumab + bevacizumabJHEP Reports · 2026
  12. Diabetes and obesity reduce FIB-4 accuracy in MASLD referral pathwaysJHEP Reports · 2026
  13. Development and patterns of acute-on-chronic liver failure in patients with cirrhosis and acute kidney injuryJHEP Reports · 2026
  14. Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinomaJHEP Reports · 2026
  15. Factors associated with protection from MASLD in type 2 diabetes: A prospective study integrating longitudinal MRI/MRE and stable isotope tracingJHEP Reports · 2026
  16. Proteome-scale autoantibody profiling in PSC: Associations with clinical phenotypes and evidence for neuroendocrine deregulationsJHEP Reports · 2025
  17. Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSCJHEP Reports · 2025
  18. Peptide YY reduces cytotoxicity of Candida albicans in alcohol-associated liver diseaseJHEP Reports · 2025
  19. Mycobiome dysbiosis and genetic predisposition to elevated IL-17A contribute to fibrosis in MASLDJHEP Reports · 2025
  20. Loss, amplification or mistiming of the daily rhythms of metabolic markers in patients with cirrhosisJHEP Reports · 2025
  21. Geography-independent mucosal microbiota alterations in primary sclerosing cholangitis persist after liver transplantationJHEP Reports · 2025
  22. The KLB rs12152703 variant confers protection against hepatic inflammation in patients with MASLD by boosting Klotho-beta expressionJHEP Reports · 2025
  23. A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cellsJHEP Reports · 2025
  24. PHENO-RAG: An artificial intelligence tool for guideline-informed management decisions in hepatocellular carcinomaJHEP Reports · 2025
  25. Sleep deprivation drives hepatic steatosis via sympathetic sprouting-induced ER stress in young male miceJHEP Reports · 2025
  26. Integration of PNPLA3 and TM6SF2 genotypes provides incremental improvement in advanced fibrosis prediction among MASLD patients with type 2 diabetes mellitusJHEP Reports · 2025
  27. Efficacy and safety of GLP-1 receptor agonists in MASH with fibrosis: A systematic review and meta-analysisJHEP Reports · 2025
  28. Radiation-induced lymphopenia is associated with survival in patients with hepatocellular carcinoma treated with stereotactic body radiotherapyJHEP Reports · 2025
  29. Multidrug-resistant colonization in decompensated cirrhosis outside the ICU predicts infection and poor outcomesJHEP Reports · 2025
  30. Complementary use of autoantibody detection methods facilitates diagnosis of juvenile autoimmune hepatitis and autoimmune sclerosing cholangitisJHEP Reports · 2025
  31. RIP3 and MLKL regulate ER stress in alcohol-associated liver disease and pharmacological ER stress models: Insights beyond necroptosisJHEP Reports · 2025
  32. Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis BJHEP Reports · 2025
  33. Steatotic liver disease and liver transplantation: Candidate selection and post-transplant managementJHEP Reports · 2025
  34. Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosisJHEP Reports · 2025
  35. Enhanced lysosomal glycogen breakdown is associated with liver tumorigenesis in glycogen storage disease type IIIJHEP Reports · 2025
  36. Outcomes after TIPS in patients with cirrhosis and sarcopenia: A systematic review and meta-analysisJHEP Reports · 2025
  37. Animal naming test at discharge is associated with hepatic encephalopathy after elective TIPSJHEP Reports · 2025
  38. Plasma IGFBP7 improves risk reclassification for liver-related outcomes: Insights from proteo-transcriptomic profilingJHEP Reports · 2025
  39. External beam radiation for HCC: Ready for incorporation into guidelines?JHEP Reports · 2025
  40. Goblet-cell muscarinic signaling at the gut barrier: A therapeutic checkpoint/target in alcohol-related liver diseaseJHEP Reports · 2025
  41. Integrating multiphase MRI surrogates to improve microvascular invasion detection and recurrence risk stratification in HCCJHEP Reports · 2025
  42. Carvedilol decreases hepatic vascular resistance by reducing fibrogenesis and reversing endothelial dysfunction in cirrhotic ratsJHEP Reports · 2025
  43. Plasma exchange as potential treatment of severe immune checkpoint inhibitor-induced hepatitisJHEP Reports · 2025
  44. Longitudinal risk of cirrhosis by steatotic liver disease subtype among 1.5 million individuals in the USJHEP Reports · 2025
  45. Inhibition of estrogen receptor alpha stabilizes regulatory T cell function in autoimmune hepatitisJHEP Reports · 2025
  46. Cumulative lipid exposure in young adulthood and risk of midlife MASLDJHEP Reports · 2025
  47. Self-supervised learning to predict intrahepatic cholangiocarcinoma transcriptomic classes on routine histologyJHEP Reports · 2025
  48. Shunt magnitude is a key determinant of overt hepatic encephalopathy in patients undergoing TIPSJHEP Reports · 2025
  49. Soluble urokinase plasminogen activator receptor is a prognostic biomarker in decompensated cirrhosisJHEP Reports · 2025
  50. Genome-wide association study identifies three PNPLA3/SAMM50 SNPs associated with HCC development in non-viral liver diseaseJHEP Reports · 2025